Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Johannesson

Showing results (111-120 of 154) with videos related to

Pageof 16
Sort By:
British Journal of Urology|November 14, 1997
Willingness to pay for reduced incontinence symptomsM Johannesson, R M O'Conor, G Kobelt-Nguyen, et al.
Lakartidningen|March 20, 1991
[Treatment of hypertension at a health center. 1: The drugs prescribed for men are much more expensive than the ones prescribed for women]M Johannesson, L Borgquist, A Elenstål, et al.
The British Journal of Dermatology|December 22, 1999
Quality of life, health-state utilities and willingness to pay in patients with psoriasis and atopic eczemaL Lundberg, M Johannesson, M Silverdahl, et al.
Pharmacoeconomics|December 9, 1992
Cost-effectiveness of antihypertensive treatment: metoprolol versus thiazide diureticsM Johannesson, J Wikstrand, B Jönsson, et al.
Journal of Internal Medicine|October 1, 1991
Cost-benefit analysis of non-pharmacological treatment of hypertensionM Johannesson, H Aberg, L Agréus, et al.
Pharmacoeconomics|December 8, 1997
The effect of changes in treatment patterns on drug expenditureU G Gerdtham, M Johannesson, B Gunnarsson, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|January 29, 2010
Cloning, purification and characterization of non-human primate 12/15-lipoxygenasesM Johannesson, L Backman, H-E Claesson, et al.
Neuroreport|January 20, 1997
Cystic fibrosis mRNA expression in rat brain: cerebral cortex and medial preoptic areaM Johannesson, N Bogdanovic, A C Nordqvist, et al.
Pharmacoeconomics|December 8, 1997
Price indices of drugs and the switching to new drugs. Two empirical examplesU G Gerdtham, M Johannesson, B Gunnarsson, et al.
Health Policy (Amsterdam, Netherlands)|October 5, 1995
Value for money? A contingent valuation study of the optimal size of the Swedish health care budgetI Eckerlund, M Johannesson, P O Johansson, et al.
Pageof 16

Showing results (111-120 of 154) with videos related to

Sort By:
Pageof 16
British Journal of Urology|November 14, 1997
Willingness to pay for reduced incontinence symptomsM Johannesson, R M O'Conor, G Kobelt-Nguyen, et al.
Lakartidningen|March 20, 1991
[Treatment of hypertension at a health center. 1: The drugs prescribed for men are much more expensive than the ones prescribed for women]M Johannesson, L Borgquist, A Elenstål, et al.
The British Journal of Dermatology|December 22, 1999
Quality of life, health-state utilities and willingness to pay in patients with psoriasis and atopic eczemaL Lundberg, M Johannesson, M Silverdahl, et al.
Pharmacoeconomics|December 9, 1992
Cost-effectiveness of antihypertensive treatment: metoprolol versus thiazide diureticsM Johannesson, J Wikstrand, B Jönsson, et al.
Journal of Internal Medicine|October 1, 1991
Cost-benefit analysis of non-pharmacological treatment of hypertensionM Johannesson, H Aberg, L Agréus, et al.
Pharmacoeconomics|December 8, 1997
The effect of changes in treatment patterns on drug expenditureU G Gerdtham, M Johannesson, B Gunnarsson, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|January 29, 2010
Cloning, purification and characterization of non-human primate 12/15-lipoxygenasesM Johannesson, L Backman, H-E Claesson, et al.
Neuroreport|January 20, 1997
Cystic fibrosis mRNA expression in rat brain: cerebral cortex and medial preoptic areaM Johannesson, N Bogdanovic, A C Nordqvist, et al.
Pharmacoeconomics|December 8, 1997
Price indices of drugs and the switching to new drugs. Two empirical examplesU G Gerdtham, M Johannesson, B Gunnarsson, et al.
Health Policy (Amsterdam, Netherlands)|October 5, 1995
Value for money? A contingent valuation study of the optimal size of the Swedish health care budgetI Eckerlund, M Johannesson, P O Johansson, et al.
Pageof 16